Gengenbacher M - Search Results

1

Nonclinical Development of BCG Replacement Vaccine Candidates.

Velmurugan K, Grode L, Chang R, Fitzpatrick M, Laddy D, Hokey D, Derrick S, Morris S, McCown D, Kidd R, Gengenbacher M, Eisele B, Kaufmann SH, Fulkerson J, Brennan MJ. Velmurugan K, et al. Among authors: gengenbacher m. Vaccines (Basel). 2013 Apr 16;1(2):120-38. doi: 10.3390/vaccines1020120. Vaccines (Basel). 2013. PMID: 26343962 Free PMC article.

2

Recombinant live vaccine candidates against tuberculosis.

Kaufmann SH, Gengenbacher M. Kaufmann SH, et al. Among authors: gengenbacher m. Curr Opin Biotechnol. 2012 Dec;23(6):900-7. doi: 10.1016/j.copbio.2012.03.007. Epub 2012 Apr 4. Curr Opin Biotechnol. 2012. PMID: 22483201 Review.

3

The BCG replacement vaccine VPM1002: from drawing board to clinical trial.

Kaufmann SH, Cotton MF, Eisele B, Gengenbacher M, Grode L, Hesseling AC, Walzl G. Kaufmann SH, et al. Among authors: gengenbacher m. Expert Rev Vaccines. 2014 May;13(5):619-30. doi: 10.1586/14760584.2014.905746. Epub 2014 Apr 7. Expert Rev Vaccines. 2014. PMID: 24702486 Review.

4

Mycobacterium tuberculosis: success through dormancy.

Gengenbacher M, Kaufmann SH. Gengenbacher M, et al. FEMS Microbiol Rev. 2012 May;36(3):514-32. doi: 10.1111/j.1574-6976.2012.00331.x. Epub 2012 Mar 8. FEMS Microbiol Rev. 2012. PMID: 22320122 Free PMC article. Review.

5

The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice.

Rao M, Vogelzang A, Kaiser P, Schuerer S, Kaufmann SH, Gengenbacher M. Rao M, et al. Among authors: gengenbacher m. PLoS One. 2013 Nov 13;8(11):e78966. doi: 10.1371/journal.pone.0078966. eCollection 2013. PLoS One. 2013. PMID: 24236077 Free PMC article.

6

Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis.

Gengenbacher M, Kaiser P, Schuerer S, Lazar D, Kaufmann SH. Gengenbacher M, et al. Microbes Infect. 2016 May;18(5):364-8. doi: 10.1016/j.micinf.2016.03.005. Epub 2016 Mar 17. Microbes Infect. 2016. PMID: 26994939 Free article.

7

Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.

Gengenbacher M, Vogelzang A, Schuerer S, Lazar D, Kaiser P, Kaufmann SH. Gengenbacher M, et al. mBio. 2014 Jun 3;5(3):e01262-14. doi: 10.1128/mBio.01262-14. mBio. 2014. PMID: 24895310 Free PMC article.

8

Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis.

Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, Kaufmann SH. Vogelzang A, et al. Among authors: gengenbacher m. J Infect Dis. 2014 Dec 15;210(12):1928-37. doi: 10.1093/infdis/jiu347. Epub 2014 Jun 18. J Infect Dis. 2014. PMID: 24943726 Free PMC article.

9

The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation.

Saiga H, Nieuwenhuizen N, Gengenbacher M, Koehler AB, Schuerer S, Moura-Alves P, Wagner I, Mollenkopf HJ, Dorhoi A, Kaufmann SH. Saiga H, et al. Among authors: gengenbacher m. J Infect Dis. 2015 Jun 1;211(11):1831-41. doi: 10.1093/infdis/jiu675. Epub 2014 Dec 11. J Infect Dis. 2015. PMID: 25505299

10

Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.

Gengenbacher M, Nieuwenhuizen N, Vogelzang A, Liu H, Kaiser P, Schuerer S, Lazar D, Wagner I, Mollenkopf HJ, Kaufmann SH. Gengenbacher M, et al. mBio. 2016 May 24;7(3):e00679-16. doi: 10.1128/mBio.00679-16. mBio. 2016. PMID: 27222470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page